230 related articles for article (PubMed ID: 28407294)
1. Altered TERT promoter and other genomic regulatory elements: occurrence and impact.
Heidenreich B; Kumar R
Int J Cancer; 2017 Sep; 141(5):867-876. PubMed ID: 28407294
[TBL] [Abstract][Full Text] [Related]
2. Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome.
Poulos RC; Thoms JA; Shah A; Beck D; Pimanda JE; Wong JW
Mol Cancer Res; 2015 Aug; 13(8):1218-26. PubMed ID: 26082173
[TBL] [Abstract][Full Text] [Related]
3. Disease-associated variants in different categories of disease located in distinct regulatory elements.
Ma M; Ru Y; Chuang LS; Hsu NY; Shi LS; Hakenberg J; Cheng WY; Uzilov A; Ding W; Glicksberg BS; Chen R
BMC Genomics; 2015; 16 Suppl 8(Suppl 8):S3. PubMed ID: 26110593
[TBL] [Abstract][Full Text] [Related]
4. Occurrence, functionality and abundance of the TERT promoter mutations.
Rachakonda S; Hoheisel JD; Kumar R
Int J Cancer; 2021 Dec; 149(11):1852-1862. PubMed ID: 34313327
[TBL] [Abstract][Full Text] [Related]
5. Nanoscale chromatin profiling of gastric adenocarcinoma reveals cancer-associated cryptic promoters and somatically acquired regulatory elements.
Muratani M; Deng N; Ooi WF; Lin SJ; Xing M; Xu C; Qamra A; Tay ST; Malik S; Wu J; Lee MH; Zhang S; Tan LL; Chua H; Wong WK; Ong HS; Ooi LL; Chow PK; Chan WH; Soo KC; Goh LK; Rozen S; Teh BT; Yu Q; Ng HH; Tan P
Nat Commun; 2014 Jul; 5():4361. PubMed ID: 25008978
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of noncoding regulatory mutations in cancer.
Weinhold N; Jacobsen A; Schultz N; Sander C; Lee W
Nat Genet; 2014 Nov; 46(11):1160-5. PubMed ID: 25261935
[TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types.
Fredriksson NJ; Ny L; Nilsson JA; Larsson E
Nat Genet; 2014 Dec; 46(12):1258-63. PubMed ID: 25383969
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of telomerase in cancer.
Akincilar SC; Unal B; Tergaonkar V
Cell Mol Life Sci; 2016 Apr; 73(8):1659-70. PubMed ID: 26846696
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an ultra-conserved putative cis-regulatory module at the mammalian telomerase reverse transcriptase gene.
Tran DA; Wong TC; Schep AN; Drewell RA
DNA Cell Biol; 2010 Sep; 29(9):499-508. PubMed ID: 20438356
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Stern JL; Theodorescu D; Vogelstein B; Papadopoulos N; Cech TR
Genes Dev; 2015 Nov; 29(21):2219-24. PubMed ID: 26515115
[TBL] [Abstract][Full Text] [Related]
11. TERT promoter mutations in cancer development.
Heidenreich B; Rachakonda PS; Hemminki K; Kumar R
Curr Opin Genet Dev; 2014 Feb; 24():30-7. PubMed ID: 24657534
[TBL] [Abstract][Full Text] [Related]
12. The role of noncoding mutations in blood cancers.
Rahman S; Mansour MR
Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31771951
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Chiba K; Johnson JZ; Vogan JM; Wagner T; Boyle JM; Hockemeyer D
Elife; 2015 Jul; 4():. PubMed ID: 26194807
[TBL] [Abstract][Full Text] [Related]
14. Large-scale identification of sequence variants influencing human transcription factor occupancy in vivo.
Maurano MT; Haugen E; Sandstrom R; Vierstra J; Shafer A; Kaul R; Stamatoyannopoulos JA
Nat Genet; 2015 Dec; 47(12):1393-401. PubMed ID: 26502339
[TBL] [Abstract][Full Text] [Related]
15. IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.
Wang J; Dayem Ullah AZ; Chelala C
Nucleic Acids Res; 2018 May; 46(8):e47. PubMed ID: 29390075
[TBL] [Abstract][Full Text] [Related]
16. An integrative analysis of non-coding regulatory DNA variations associated with autism spectrum disorder.
Williams SM; An JY; Edson J; Watts M; Murigneux V; Whitehouse AJO; Jackson CJ; Bellgrove MA; Cristino AS; Claudianos C
Mol Psychiatry; 2019 Nov; 24(11):1707-1719. PubMed ID: 29703944
[TBL] [Abstract][Full Text] [Related]
17. Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study.
Wu S; Huang P; Li C; Huang Y; Li X; Wang Y; Chen C; Lv Z; Tang A; Sun X; Lu J; Li W; Zhou J; Gui Y; Zhou F; Wang D; Cai Z
Eur Urol; 2014 Feb; 65(2):274-7. PubMed ID: 24215939
[TBL] [Abstract][Full Text] [Related]
18. Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation.
Akıncılar SC; Khattar E; Boon PL; Unal B; Fullwood MJ; Tergaonkar V
Cancer Discov; 2016 Nov; 6(11):1276-1291. PubMed ID: 27650951
[TBL] [Abstract][Full Text] [Related]
19. Network perturbation by recurrent regulatory variants in cancer.
Jang K; Kim K; Cho A; Lee I; Choi JK
PLoS Comput Biol; 2017 Mar; 13(3):e1005449. PubMed ID: 28333928
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations.
Maryoung L; Yue Y; Young A; Newton CA; Barba C; van Oers NS; Wang RC; Garcia CK
J Clin Invest; 2017 Mar; 127(3):982-986. PubMed ID: 28192371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
